11
TITLE: Preclinical models and technologies to advance nanovaccine development  Full Text
AUTHORS: Peres, C; Matos, AI; Moura, LIF; Acurcio, RC; Carreira, B; Pozzi, S; Vaskovich Koubi, D; Kleiner, R; Satchi Fainaro, R; Florindo, HF;
PUBLISHED: 2021, SOURCE: ADVANCED DRUG DELIVERY REVIEWS, VOLUME: 172
INDEXED IN: Scopus WOS
12
TITLE: Special Issue "A perspective of drug delivery and translational research in Europe"
AUTHORS: Blanco Prieto, MJ; Florindo, HF;
PUBLISHED: 2021, SOURCE: DRUG DELIVERY AND TRANSLATIONAL RESEARCH, VOLUME: 11, ISSUE: 2
INDEXED IN: WOS
13
TITLE: Selenium Nanoparticles for Biomedical Applications: From Development and Characterization to Therapeutics  Full Text
AUTHORS: Ferro, C; Florindo, HF; Santos, HA;
PUBLISHED: 2021, SOURCE: ADVANCED HEALTHCARE MATERIALS
INDEXED IN: WOS
14
TITLE: Current hurdles to the translation of nanomedicines from bench to the clinic
AUTHORS: Dordevic, S; Gonzalez, MM; Conejos Sanchez, I; Carreira, B; Pozzi, S; Acurcio, RC; Satchi Fainaro, R; Florindo, HF; Vicent, MJ;
PUBLISHED: 2021, SOURCE: DRUG DELIVERY AND TRANSLATIONAL RESEARCH
INDEXED IN: WOS
15
TITLE: Design of Experiments to Achieve an Efficient Chitosan-Based DNA Vaccine Delivery System  Full Text
AUTHORS: Rodolfo, C; Eusebio, D; Ventura, C; Nunes, R; Florindo, HF; Costa, D; Sousa, A;
PUBLISHED: 2021, SOURCE: PHARMACEUTICS, VOLUME: 13, ISSUE: 9
INDEXED IN: Scopus WOS
16
TITLE: Immune-mediated approaches against COVID-19
AUTHORS: Helena F Florindo; Ron Kleiner; Daniella Vaskovich Koubi; Rita C Acurcio; Barbara Carreira; Eilam Yeini; Galia Tiram; Yulia Liubomirski; Ronit Satchi Fainaro;
PUBLISHED: 2020, SOURCE: NATURE NANOTECHNOLOGY, VOLUME: 15, ISSUE: 8
INDEXED IN: Scopus WOS
17
TITLE: Cisplatin-Membrane Interactions and Their Influence on Platinum Complexes Activity and Toxicity  Full Text
AUTHORS: Nuno Martinho; Tania C B Santos; Helena F Florindo; Liana C Silva;
PUBLISHED: 2019, SOURCE: FRONTIERS IN PHYSIOLOGY, VOLUME: 9, ISSUE: JAN
INDEXED IN: Scopus WOS
18
TITLE: Computer-aided drug design in new druggable targets for the next generation of immune-oncology therapies  Full Text
AUTHORS: Rita C Acurcio; Anna Scomparin; Ronit Satchi Fainaro; Helena F Florindo; Rita C Guedes;
PUBLISHED: 2019, SOURCE: WILEY INTERDISCIPLINARY REVIEWS-COMPUTATIONAL MOLECULAR SCIENCE, VOLUME: 9, ISSUE: 3
INDEXED IN: WOS
19
TITLE: DC Respond to Cognate T Cell Interaction in the Antigen-Challenged Lymph Node  Full Text
AUTHORS: Caterina Curato; Biana Bernshtein; Eva Zupancic; Almut Dufner; Diego Jaitin; Amir Giladi; Eyal David; Louise Chappell Maor; Dena Leshkowitz; Klaus Peter Knobeloch; Ido Amit; Helena F Florindo; Steffen Jung;
PUBLISHED: 2019, SOURCE: FRONTIERS IN IMMUNOLOGY, VOLUME: 10
INDEXED IN: Scopus WOS
20
TITLE: Nanotechnology is an important strategy for combinational innovative chemo-immunotherapies against colorectal cancer  Full Text
AUTHORS: Ana I Matos; Barbara Carreira; Carina Peres; Liane I F Moura; Joao Conniot; Thibaut Fourniols; Anna Scomparin; Agueda Martinez Barriocanal; Diego Arango; Joao P Conde; Veronique Preat; Ronit Satchi Fainaro; Helena F Florindo;
PUBLISHED: 2019, SOURCE: Annual Meeting of the Controlled-Release-Society (CRS) in JOURNAL OF CONTROLLED RELEASE, VOLUME: 307
INDEXED IN: Scopus WOS
Page 2 of 6. Total results: 56.